Hani Gabra
Fondateur chez Papyrus Therapeutics, Inc.
Postes actifs de Hani Gabra
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Imperial College London | Corporate Officer/Principal | - | - |
Papyrus Therapeutics, Inc.
 Papyrus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation. | Directeur Technique/Scientifique/R&D | - | - |
| Fondateur | - | - |
Historique de carrière de Hani Gabra
Anciens postes connus de Hani Gabra
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BERGENBIO ASA | Directeur Technique/Scientifique/R&D | 01/09/2019 | - |
| Corporate Officer/Principal | 06/08/2021 | 01/05/2022 | |
| ASTRAZENECA PLC | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Royaume-Uni | 3 |
| Norvège | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BERGENBIO ASA | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Papyrus Therapeutics, Inc.
Papyrus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation. | Commercial Services |
- Bourse
- Insiders
- Hani Gabra
- Expérience
